P Phani Sekhar of Karvy Stock Broking told CNBC-TV18, "There are very few choices among the largecaps, both Sun Pharmaceutical Industries as well as Dr Reddy's Laboratories look okay but I think the real action is in the midcap space and our top pick continues to be Aurobindo Pharma."On Wednesday, Aurobindo Pharma closed at Rs 817.30, up Rs 26.50, or 3.35 percent. It has touched an intraday high of Rs 824.50 and an intraday low of Rs 775.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
